Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

AMA, AAP, IDSA Among Organizations Disinvited From CDC Vaccine Workgroups

U.S. health officials have informed more than half a dozen leading medical organizations that they will no longer be invited to participate in developing vaccin

Adjusted Mortality Rate Increased for Seniors After Hurricane-Related Flooding

For older adults, the overall adjusted mortality risk is higher in flooded regions versus nonflooded regions for up to five years after hurricane landfall, acco

CDC Warns Travelers After 8,000+ Chikungunya Cases Reported in China

FRIDAY, Aug. 8, 2025 Health officials in China are reporting more than 8,000 cases of chikungunya, a virus spread by mosquitoes that can cause fever and painful

New Weight Loss Pill From Eli Lilly, Orforglipron, Shows Promise in Early Study

FRIDAY, Aug. 8, 2025 A new weight loss pill made by Eli Lilly helped people lose a significant amount of weight in a recent study. Taken at the highest dose, or

Tiny Traces of Lithium May Help Protect the Brain From Alzheimer’s

FRIDAY, Aug. 8, 2025 Tiny amounts of lithium a natural metal may help protect the brain from Alzheimer s and signs of aging, new research shows. Scientists at H

Increase Seen in Nitrous Oxide-Related Mortality From 2010 to 2023

From 2010 to 2023, there was an increase in nitrous oxide-related mortality, with the trend significant through 2018, according to a research letter published o

People With Disabilities Have High Rates of Loneliness

Loneliness among people with disabilities (PWD) is high, according to a study published online Aug. 5 in the Annals of Internal Medicine. Maggie Salinger, M.D.,

Use of HEPA Filters Tied to Reduced Systolic BP

The use of in-home high-efficiency particulate arrestance (HEPA) filters is associated with reductions in systolic blood pressure (SBP) among individuals with e

Sustained Clinical Benefit Seen for Pembrolizumab + Axitinib in Advanced Renal Cancer

For patients with advanced renal cell carcinoma (RCC), there is a sustained clinical benefit with pembrolizumab plus axitinib, according to a study published on

Broader Formulary Coverage Linked to Lower Odds of MS Relapse

Broader formulary coverage is associated with lower odds of multiple sclerosis (MS) relapse among Medicare beneficiaries, according to a study published online

Popular Keywords